Literature DB >> 12408974

Attenuated signaling associated with immune activation in HIV-1-infected individuals.

Qibin Leng1, Gadi Borkow, Zvi Bentwich.   

Abstract

Chronic immune activation is associated with impaired signal transduction. Since such activation is commonly found during HIV-1 infection, we studied cellular responses to non-specific T-cell receptor stimulation of PBMC obtained from 20 HIV-1 non-infected individuals and 23 highly or partially immune activated HIV-1 infected individuals. PBMC proliferation and ERK-1/2 phosphorylation following anti-CD3 stimulation, and constitutive levels of Cbl-b, were determined. Increased levels of Cbl-b, decreased proliferation, and lower ERK-1/2 phosphorylation were found in PBMC of highly immune activated HIV-1 infected individuals. The elevated expression of Cbl-b and impaired phosphorylation of ERK-1/2 associated with immune activation probably contribute to the attenuated proliferative and cellular responses characteristic of HIV-1 infection. Therefore, targeting immune negative modulators, such as Cbl-b, may serve as a novel approach for controlling HIV-1 disease progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408974     DOI: 10.1016/s0006-291x(02)02460-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses.

Authors:  Timothy Q Crawford; Lishomwa C Ndhlovu; Alice Tan; Alex Carvidi; Frederick M Hecht; Elizabeth Sinclair; Jason D Barbour
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 2.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response.

Authors:  Robert L Furler; Christel H Uittenbogaart
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

3.  Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells.

Authors:  Martin D Hyrcza; Colin Kovacs; Mona Loutfy; Roberta Halpenny; Lawrence Heisler; Stuart Yang; Olivia Wilkins; Mario Ostrowski; Sandy D Der
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

Review 4.  c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.

Authors:  Christine B F Thien; Wallace Y Langdon
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

5.  Elevation of immune activation in kenyan women is associated with alterations in immune function: implications for vaccine development.

Authors:  Sandra A Koesters; Lucy Matu; Peter Kiama; Omu Anzala; Joanne Embree; Francis A Plummer; Joshua Kimani; Keith R Fowke
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

Review 6.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells.

Authors:  Nicolò C Brembilla; Johann Weber; Donata Rimoldi; Sylvain Pradervand; Frédéric Schütz; Giuseppe Pantaleo; Curzio Rüegg; Manfredo Quadroni; Keith Harshman; Marie-Agnès Doucey
Journal:  Blood       Date:  2008-05-27       Impact factor: 22.113

8.  High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.

Authors:  Amy Y Liu; Stephen C De Rosa; Brandon L Guthrie; Robert Y Choi; Rose Kerubo-Bosire; Barbra A Richardson; James Kiarie; Carey Farquhar; Barbara Lohman-Payne
Journal:  Immun Inflamm Dis       Date:  2018-07-04

9.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.